Nuwellis appoints Dr. Archelle Georgiou and David McDonald to board; Jon Salveson resigns

Nuwellis, Inc.

Dr. Archelle Georgiou appointed to Board effective Nov 1, 2023; will chair Nominating & Governance and serve on Compensation Committee.
David McDonald appointed to Board effective Nov 1, 2023; will serve on Audit and Nominating & Governance Committees.
Jon Salveson resigned effective Oct 31, 2023; resignation not due to any disagreement with the company.
New directors receive $45,000 annual retainer plus additional committee fees; both deemed independent.
McDonald is head of Life Science Investment Banking at Lake Street; Georgiou is former CMO at UnitedHealth Group.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Archelle Georgiou

Director

NUWE · Nuwellis, Inc.

Effective: 2023-11-01
Filed: November 1, 2023, 7:59 PM ET

the appointment of Archelle Georgiou (Feldshon) , M.D. to its Board

Appointed

David McDonald

Director

NUWE · Nuwellis, Inc.

Effective: 2023-11-01
Filed: November 1, 2023, 7:59 PM ET

the appointment of David McDonald to its Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Archelle Georgiou was appointed as Director at Nuwellis, Inc..

Action: appointed
Role: Director

Exact text from the filing

the appointment of Archelle Georgiou (Feldshon) , M.D. to its Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David McDonald was appointed as Director at Nuwellis, Inc..

Action: appointed
Role: Director

Exact text from the filing

the appointment of David McDonald to its Board

View on SEC.gov

Nuwellis, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-050839

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.